More than 50% of cancer patients worldwide require some form of radiation during their treatment journey, and a growing proportion now benefit from advanced approaches such as systemic radiation therapy. This evolution has transformed cancer care from localized radiation alone to precision-driven internal therapies that travel through the body to target disease wherever it exists. At the forefront of delivering these sophisticated treatments is Dr Mathangi J, Senior Consultant and In-charge of Radiation Oncology at Gleneagles Cancer Institute, Bangalore, whose clinical expertise ensures that patients receive not just treatment, but confidence, clarity, and hope.
Systemic radiation is a form of internal radiation treatment where radioactive substances are introduced into the body to locate and destroy cancer cells. Unlike external beam radiation that targets a defined area, this approach allows radiation to circulate through the bloodstream, making it especially effective for cancers that are widespread or have microscopic spread.
Also known clinically as radionuclide therapy, this method uses carefully selected radioactive compounds that emit radiation over a controlled distance. Once administered, these compounds naturally seek out cancer cells based on biological pathways, delivering radiation directly where it is needed most while sparing healthy tissues.
The demand for systemic radiation therapy has risen because it solves a critical problem in oncology: treating cancers that cannot be adequately controlled with surgery or localized radiation alone. Many cancers spread through blood or lymphatic systems, making whole-body targeting essential.
Under the leadership of Dr Mathangi, patients receive treatment plans that integrate systemic therapies with advanced external techniques when appropriate. This ensures a comprehensive, personalized approach rather than a one-size-fits-all protocol.
Radionuclide therapy works by pairing a radioactive isotope with a molecule that cancer cells naturally absorb. These molecules act as delivery vehicles, guiding radiation directly to tumor cells. Once inside or attached to the cancer cell, radiation damages its DNA, preventing further growth and triggering cell death.
This concept forms the basis of targeted radioactive drugs, which are designed to recognize specific receptors or metabolic pathways unique to cancer cells. The precision of this method is what sets modern systemic radiation apart from older, less selective treatments.
A common concern among patients is safety. Radioactive injection treatment is administered in strictly controlled clinical environments by trained radiation oncologists. Dosages are calculated with extreme precision, taking into account tumor type, size, spread, and the patient’s overall health.
Dr Mathangi’s extensive experience with over 12,000 successfully treated patients ensures that every step—from preparation to post-treatment monitoring—is conducted with rigorous safety standards. Patients are guided clearly on precautions, recovery expectations, and follow-up care.
Whole-body radiation medicine differs fundamentally from external radiation therapies. Instead of directing radiation beams from outside the body, the radiation source is placed inside the body, allowing it to travel naturally to cancer cells wherever they are located.
This makes it particularly valuable in cancers that:
At Gleneagles Cancer Institute, Dr Mathangi integrates this approach with cutting-edge imaging and planning technologies to ensure maximum effectiveness with minimal side effects.
Cancer systemic radiation plays a vital role in the management of several malignancies, either as a primary treatment or as part of a combined modality approach. According to Dr Mathangi’s clinical practice, radiation therapy is commonly required for:
The decision to use systemic approaches depends on disease behavior, imaging findings, and patient-specific factors—areas where Dr Mathangi’s experience and judgment make a decisive difference.
Systemic radiation is not merely about administering a radioactive compound; it demands deep expertise in oncology biology, radiation physics, imaging interpretation, and patient management. Errors in planning or execution can compromise outcomes.
Dr Mathangi J brings over two decades of experience, advanced international training from Germany and Denmark, and leadership in installing Asia Pacific’s first TrueBeam STx Machine. Her ability to integrate systemic therapies with techniques such as SBRT, IGRT, RapidArc, and image-guided brachytherapy ensures patients receive world-class care in India.
Patients undergoing systemic radiation under Dr Mathangi’s supervision are supported throughout their journey—from initial consultation to recovery. Treatment plans are explained clearly, anxiety is addressed empathetically, and outcomes are monitored meticulously.
Many patients express relief in knowing that their treatment is overseen by a specialist who combines technical excellence with genuine compassion. This trust translates into better adherence, smoother recovery, and improved overall outcomes.
Delaying or avoiding advanced radiation options can allow disease progression, reduce treatment effectiveness, and increase symptom burden. Patients who postpone expert evaluation often lose the opportunity for optimal outcomes.
Choosing Dr Mathangi early in the treatment pathway ensures access to advanced systemic and precision radiation options when they can make the greatest impact.
Patients seeking expert evaluation for systemic radiation and advanced cancer care can submit their contact information through the official form at https://drmathangi.com/contact/. Dr Mathangi’s team will coordinate the appointment and provide timely updates, ensuring a seamless and supportive experience.
Dr Mathangi J is a Senior Consultant and In-charge of Radiation Oncology at Gleneagles Cancer Institute, Bangalore. With qualifications including MBBS, DMRT, and DNB, and over 20 years of clinical experience, she is recognized as one of India’s most accomplished radiation oncologists.
She has received advanced international training in stereotactic techniques, IGRT, RapidArc, and intraoperative radiotherapy, and currently serves as Director of Fellowship in Advanced Radiotherapy Techniques affiliated with RGUHS. Her commitment to excellence, innovation, and patient-centered care makes her a trusted choice for patients across South and North India.
Systemic radiation therapy is a form of internal treatment where radioactive substances are introduced into the body to travel through the bloodstream and reach cancer cells wherever they are located. Unlike external radiation, which targets a specific area from outside the body, this approach allows treatment of cancers that are widespread or difficult to localize.
Radionuclide therapy uses specially designed radioactive molecules that circulate in the body and bind to cancer cells. Once attached, they release controlled radiation that damages cancer cells from within, while minimizing exposure to most healthy tissues.
Radioactive injection treatment is considered safe when administered under strict medical supervision. Dr. Mathangi carefully evaluates each patient’s condition, selects the appropriate dose, and monitors response and side effects to ensure safety throughout the treatment journey.
Whole-body radiation medicine is often used for cancers that have spread to multiple areas, such as certain thyroid cancers, neuroendocrine tumors, and metastatic bone disease. Dr. Mathangi determines suitability based on cancer type, stage, and individual patient factors.
Targeted radioactive drugs are designed to seek out specific cancer cells, delivering radiation directly to them. Unlike chemotherapy, which can affect many fast-growing cells in the body, this targeted approach helps reduce systemic side effects while maintaining treatment effectiveness.
Cancer systemic radiation may be recommended when cancer has spread beyond a single location or when other treatments are less effective. Dr. Mathangi emphasizes a personalized approach, combining detailed diagnostics with patient goals to decide the best course of care.
Patients can expect careful monitoring before, during, and after treatment. Mild side effects such as fatigue may occur, but most patients resume daily activities quickly. Dr. Mathangi and her team provide clear guidance, follow-up plans, and supportive care throughout recovery.
Your information is kept strictly confidential.
